Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster
Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depre...
Gespeichert in:
Veröffentlicht in: | Pharmacology, biochemistry and behavior biochemistry and behavior, 2014-03, Vol.118, p.79-86 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 86 |
---|---|
container_issue | |
container_start_page | 79 |
container_title | Pharmacology, biochemistry and behavior |
container_volume | 118 |
creator | Alò, Raffaella Avolio, Ennio Mele, Maria Storino, Francesca Canonaco, Alessia Carelli, Antonio Canonaco, Marcello |
description | Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depressant behaviors in the hibernating hamster (Mesocricetus auratus) via infusion of CeA with the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) specific for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plus the specific agonist for α4 GABAAR i.e. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP). Treatment with CNQX appeared to mainly prompt anti-depressant effects as shown by the achievements of swimming feats during forced swim test while THIP prevalently accounted for evident bouts of climbing when exposed to the same test. Moreover, even in the presence of the concomitant administration of both of these compounds, hamsters continued to spend more time in swimming despite this significant behavioral effect resulted to be numerically reduced for hamsters treated with only the α4 GABAAR agonist. Conversely, when these animals were tested in elevated plus maze (EPM), THIP tended to mostly favor anxiolytic activities as exhibited by stressed animals spending more time entering and remaining in EPM open arms. It was interesting to note that behavioral changes induced by both drugs appeared to be also responsible for glutamate receptor (GluR) expression differences as indicated by CNQX favoring an evident up-regulation of GluR2-containing neurons whereas THIP induced an up-regulation, this time of GluR1-containing neurons. Overall, the anti-depressant role of CNQX seems to be mostly attributed to elevated GluR2 levels while an anxiolytic-like effect of THIP was correlated to high GluR1values thereby proposing distinct GluRs as useful therapeutic sites against degenerative diseases such as depression-like behaviors.
•Mainly CNQX but also THIP promoted anti-depressant effects.•CNQX was prevalently linked to evident bouts of swimming.•CNQX-dependent swimming performances were correlated to GluR2 mRNA levels.•THIP-related greater open-arm entries were correlated to GluR1 mRNA levels.•AMPAR subtypes represent targets for the treatment of mood disorders. |
doi_str_mv | 10.1016/j.pbb.2014.01.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1500693487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305714000161</els_id><sourcerecordid>1500693487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-423fe6864c0a85dccc7c0d08c91688040dede04de2479b92e251858cfef3a05d3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVJaTbb_oBeio652BnZsi2TUwnbphDopT0LWRpnZ_HHRpJDFvLjo80mPfYwaATv-8A8jH0VkAsQ9dUu33ddXoCQOYgcoPnAVkI1ZVaJpjljK4BWZCVUzTm7CGEHALKom0_svJCyVqm2Ys-bJ0vRxNkfrmjaUkfHlePDQgN1npaRzz2PW-QWp-jNwM14uHdmMHxa7IBL4PcmYuBmipQ53HsMgR4x_V2aJ5qHQyTLQ3xN0fTK2poxRPSf2cfeDAG_vL1r9vfH5s_NbXb3--evm-93mS2rMmayKHusVS0tGFU5a21jwYGyraiVAgkOHYJ0WMim7doCi0qoStke-9JA5co1uzxx935-WDBEPVKwOAxmwnkJWlQAdVvKpG7NxClq_RyCx17vPY3GH7QAfZSudzpJ10fpGoRO0lPn2xt-6UZ0_xrvllPg-hTAdOQjodfBEk4WHXm0UbuZ_oN_AYHFlRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1500693487</pqid></control><display><type>article</type><title>Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Alò, Raffaella ; Avolio, Ennio ; Mele, Maria ; Storino, Francesca ; Canonaco, Alessia ; Carelli, Antonio ; Canonaco, Marcello</creator><creatorcontrib>Alò, Raffaella ; Avolio, Ennio ; Mele, Maria ; Storino, Francesca ; Canonaco, Alessia ; Carelli, Antonio ; Canonaco, Marcello</creatorcontrib><description>Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depressant behaviors in the hibernating hamster (Mesocricetus auratus) via infusion of CeA with the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) specific for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plus the specific agonist for α4 GABAAR i.e. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP). Treatment with CNQX appeared to mainly prompt anti-depressant effects as shown by the achievements of swimming feats during forced swim test while THIP prevalently accounted for evident bouts of climbing when exposed to the same test. Moreover, even in the presence of the concomitant administration of both of these compounds, hamsters continued to spend more time in swimming despite this significant behavioral effect resulted to be numerically reduced for hamsters treated with only the α4 GABAAR agonist. Conversely, when these animals were tested in elevated plus maze (EPM), THIP tended to mostly favor anxiolytic activities as exhibited by stressed animals spending more time entering and remaining in EPM open arms. It was interesting to note that behavioral changes induced by both drugs appeared to be also responsible for glutamate receptor (GluR) expression differences as indicated by CNQX favoring an evident up-regulation of GluR2-containing neurons whereas THIP induced an up-regulation, this time of GluR1-containing neurons. Overall, the anti-depressant role of CNQX seems to be mostly attributed to elevated GluR2 levels while an anxiolytic-like effect of THIP was correlated to high GluR1values thereby proposing distinct GluRs as useful therapeutic sites against degenerative diseases such as depression-like behaviors.
•Mainly CNQX but also THIP promoted anti-depressant effects.•CNQX was prevalently linked to evident bouts of swimming.•CNQX-dependent swimming performances were correlated to GluR2 mRNA levels.•THIP-related greater open-arm entries were correlated to GluR1 mRNA levels.•AMPAR subtypes represent targets for the treatment of mood disorders.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/j.pbb.2014.01.007</identifier><identifier>PMID: 24468014</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>6-Cyano-7-nitroquinoxaline-2,3-dione - administration & dosage ; AMPAR ; Amygdala - drug effects ; Amygdala - physiopathology ; Animals ; Anxiety - drug therapy ; Anxiety - genetics ; Anxiety - physiopathology ; Behavior, Animal - drug effects ; Behavior, Animal - physiology ; Central amygdala nucleus ; Cricetinae ; Depression - drug therapy ; Depression - genetics ; Depression - physiopathology ; Excitatory Amino Acid Antagonists - administration & dosage ; Forced swim test ; GABA-A Receptor Agonists - administration & dosage ; GABAAR ; Isoxazoles - administration & dosage ; Male ; Mesocricetus ; Microinjections ; Receptors, AMPA - drug effects ; Receptors, AMPA - genetics ; Receptors, AMPA - physiology ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Stress, Physiological</subject><ispartof>Pharmacology, biochemistry and behavior, 2014-03, Vol.118, p.79-86</ispartof><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-423fe6864c0a85dccc7c0d08c91688040dede04de2479b92e251858cfef3a05d3</citedby><cites>FETCH-LOGICAL-c353t-423fe6864c0a85dccc7c0d08c91688040dede04de2479b92e251858cfef3a05d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091305714000161$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24468014$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alò, Raffaella</creatorcontrib><creatorcontrib>Avolio, Ennio</creatorcontrib><creatorcontrib>Mele, Maria</creatorcontrib><creatorcontrib>Storino, Francesca</creatorcontrib><creatorcontrib>Canonaco, Alessia</creatorcontrib><creatorcontrib>Carelli, Antonio</creatorcontrib><creatorcontrib>Canonaco, Marcello</creatorcontrib><title>Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depressant behaviors in the hibernating hamster (Mesocricetus auratus) via infusion of CeA with the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) specific for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plus the specific agonist for α4 GABAAR i.e. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP). Treatment with CNQX appeared to mainly prompt anti-depressant effects as shown by the achievements of swimming feats during forced swim test while THIP prevalently accounted for evident bouts of climbing when exposed to the same test. Moreover, even in the presence of the concomitant administration of both of these compounds, hamsters continued to spend more time in swimming despite this significant behavioral effect resulted to be numerically reduced for hamsters treated with only the α4 GABAAR agonist. Conversely, when these animals were tested in elevated plus maze (EPM), THIP tended to mostly favor anxiolytic activities as exhibited by stressed animals spending more time entering and remaining in EPM open arms. It was interesting to note that behavioral changes induced by both drugs appeared to be also responsible for glutamate receptor (GluR) expression differences as indicated by CNQX favoring an evident up-regulation of GluR2-containing neurons whereas THIP induced an up-regulation, this time of GluR1-containing neurons. Overall, the anti-depressant role of CNQX seems to be mostly attributed to elevated GluR2 levels while an anxiolytic-like effect of THIP was correlated to high GluR1values thereby proposing distinct GluRs as useful therapeutic sites against degenerative diseases such as depression-like behaviors.
•Mainly CNQX but also THIP promoted anti-depressant effects.•CNQX was prevalently linked to evident bouts of swimming.•CNQX-dependent swimming performances were correlated to GluR2 mRNA levels.•THIP-related greater open-arm entries were correlated to GluR1 mRNA levels.•AMPAR subtypes represent targets for the treatment of mood disorders.</description><subject>6-Cyano-7-nitroquinoxaline-2,3-dione - administration & dosage</subject><subject>AMPAR</subject><subject>Amygdala - drug effects</subject><subject>Amygdala - physiopathology</subject><subject>Animals</subject><subject>Anxiety - drug therapy</subject><subject>Anxiety - genetics</subject><subject>Anxiety - physiopathology</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavior, Animal - physiology</subject><subject>Central amygdala nucleus</subject><subject>Cricetinae</subject><subject>Depression - drug therapy</subject><subject>Depression - genetics</subject><subject>Depression - physiopathology</subject><subject>Excitatory Amino Acid Antagonists - administration & dosage</subject><subject>Forced swim test</subject><subject>GABA-A Receptor Agonists - administration & dosage</subject><subject>GABAAR</subject><subject>Isoxazoles - administration & dosage</subject><subject>Male</subject><subject>Mesocricetus</subject><subject>Microinjections</subject><subject>Receptors, AMPA - drug effects</subject><subject>Receptors, AMPA - genetics</subject><subject>Receptors, AMPA - physiology</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Stress, Physiological</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVJaTbb_oBeio652BnZsi2TUwnbphDopT0LWRpnZ_HHRpJDFvLjo80mPfYwaATv-8A8jH0VkAsQ9dUu33ddXoCQOYgcoPnAVkI1ZVaJpjljK4BWZCVUzTm7CGEHALKom0_svJCyVqm2Ys-bJ0vRxNkfrmjaUkfHlePDQgN1npaRzz2PW-QWp-jNwM14uHdmMHxa7IBL4PcmYuBmipQ53HsMgR4x_V2aJ5qHQyTLQ3xN0fTK2poxRPSf2cfeDAG_vL1r9vfH5s_NbXb3--evm-93mS2rMmayKHusVS0tGFU5a21jwYGyraiVAgkOHYJ0WMim7doCi0qoStke-9JA5co1uzxx935-WDBEPVKwOAxmwnkJWlQAdVvKpG7NxClq_RyCx17vPY3GH7QAfZSudzpJ10fpGoRO0lPn2xt-6UZ0_xrvllPg-hTAdOQjodfBEk4WHXm0UbuZ_oN_AYHFlRs</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Alò, Raffaella</creator><creator>Avolio, Ennio</creator><creator>Mele, Maria</creator><creator>Storino, Francesca</creator><creator>Canonaco, Alessia</creator><creator>Carelli, Antonio</creator><creator>Canonaco, Marcello</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201403</creationdate><title>Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster</title><author>Alò, Raffaella ; Avolio, Ennio ; Mele, Maria ; Storino, Francesca ; Canonaco, Alessia ; Carelli, Antonio ; Canonaco, Marcello</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-423fe6864c0a85dccc7c0d08c91688040dede04de2479b92e251858cfef3a05d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>6-Cyano-7-nitroquinoxaline-2,3-dione - administration & dosage</topic><topic>AMPAR</topic><topic>Amygdala - drug effects</topic><topic>Amygdala - physiopathology</topic><topic>Animals</topic><topic>Anxiety - drug therapy</topic><topic>Anxiety - genetics</topic><topic>Anxiety - physiopathology</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavior, Animal - physiology</topic><topic>Central amygdala nucleus</topic><topic>Cricetinae</topic><topic>Depression - drug therapy</topic><topic>Depression - genetics</topic><topic>Depression - physiopathology</topic><topic>Excitatory Amino Acid Antagonists - administration & dosage</topic><topic>Forced swim test</topic><topic>GABA-A Receptor Agonists - administration & dosage</topic><topic>GABAAR</topic><topic>Isoxazoles - administration & dosage</topic><topic>Male</topic><topic>Mesocricetus</topic><topic>Microinjections</topic><topic>Receptors, AMPA - drug effects</topic><topic>Receptors, AMPA - genetics</topic><topic>Receptors, AMPA - physiology</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Stress, Physiological</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alò, Raffaella</creatorcontrib><creatorcontrib>Avolio, Ennio</creatorcontrib><creatorcontrib>Mele, Maria</creatorcontrib><creatorcontrib>Storino, Francesca</creatorcontrib><creatorcontrib>Canonaco, Alessia</creatorcontrib><creatorcontrib>Carelli, Antonio</creatorcontrib><creatorcontrib>Canonaco, Marcello</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alò, Raffaella</au><au>Avolio, Ennio</au><au>Mele, Maria</au><au>Storino, Francesca</au><au>Canonaco, Alessia</au><au>Carelli, Antonio</au><au>Canonaco, Marcello</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2014-03</date><risdate>2014</risdate><volume>118</volume><spage>79</spage><epage>86</epage><pages>79-86</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><abstract>Several studies have pointed to the amygdala as a main limbic station capable of regulating different stressful states such as anxiety and depression. In this work it was our intention to determine the role of the central amygdala nucleus (CeA) on the execution of either anxiolytic and/or anti-depressant behaviors in the hibernating hamster (Mesocricetus auratus) via infusion of CeA with the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) specific for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) plus the specific agonist for α4 GABAAR i.e. 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP). Treatment with CNQX appeared to mainly prompt anti-depressant effects as shown by the achievements of swimming feats during forced swim test while THIP prevalently accounted for evident bouts of climbing when exposed to the same test. Moreover, even in the presence of the concomitant administration of both of these compounds, hamsters continued to spend more time in swimming despite this significant behavioral effect resulted to be numerically reduced for hamsters treated with only the α4 GABAAR agonist. Conversely, when these animals were tested in elevated plus maze (EPM), THIP tended to mostly favor anxiolytic activities as exhibited by stressed animals spending more time entering and remaining in EPM open arms. It was interesting to note that behavioral changes induced by both drugs appeared to be also responsible for glutamate receptor (GluR) expression differences as indicated by CNQX favoring an evident up-regulation of GluR2-containing neurons whereas THIP induced an up-regulation, this time of GluR1-containing neurons. Overall, the anti-depressant role of CNQX seems to be mostly attributed to elevated GluR2 levels while an anxiolytic-like effect of THIP was correlated to high GluR1values thereby proposing distinct GluRs as useful therapeutic sites against degenerative diseases such as depression-like behaviors.
•Mainly CNQX but also THIP promoted anti-depressant effects.•CNQX was prevalently linked to evident bouts of swimming.•CNQX-dependent swimming performances were correlated to GluR2 mRNA levels.•THIP-related greater open-arm entries were correlated to GluR1 mRNA levels.•AMPAR subtypes represent targets for the treatment of mood disorders.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24468014</pmid><doi>10.1016/j.pbb.2014.01.007</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-3057 |
ispartof | Pharmacology, biochemistry and behavior, 2014-03, Vol.118, p.79-86 |
issn | 0091-3057 1873-5177 |
language | eng |
recordid | cdi_proquest_miscellaneous_1500693487 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | 6-Cyano-7-nitroquinoxaline-2,3-dione - administration & dosage AMPAR Amygdala - drug effects Amygdala - physiopathology Animals Anxiety - drug therapy Anxiety - genetics Anxiety - physiopathology Behavior, Animal - drug effects Behavior, Animal - physiology Central amygdala nucleus Cricetinae Depression - drug therapy Depression - genetics Depression - physiopathology Excitatory Amino Acid Antagonists - administration & dosage Forced swim test GABA-A Receptor Agonists - administration & dosage GABAAR Isoxazoles - administration & dosage Male Mesocricetus Microinjections Receptors, AMPA - drug effects Receptors, AMPA - genetics Receptors, AMPA - physiology RNA, Messenger - genetics RNA, Messenger - metabolism Stress, Physiological |
title | Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T10%3A19%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Excitatory/inhibitory%20equilibrium%20of%20the%20central%20amygdala%20nucleus%20gates%20anti-depressive%20and%20anxiolytic%20states%20in%20the%20hamster&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Al%C3%B2,%20Raffaella&rft.date=2014-03&rft.volume=118&rft.spage=79&rft.epage=86&rft.pages=79-86&rft.issn=0091-3057&rft.eissn=1873-5177&rft_id=info:doi/10.1016/j.pbb.2014.01.007&rft_dat=%3Cproquest_cross%3E1500693487%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1500693487&rft_id=info:pmid/24468014&rft_els_id=S0091305714000161&rfr_iscdi=true |